PROBLEM TO BE SOLVED: To provide methods of using anti-NGF antibodies in treatment of various NGF-related disorders, including asthma, arthritis and psoriasis.SOLUTION: A method of controlling an NGF-related disorder in a human patient comprises administering to a human patient an effective amount of an anti-human NGF (anti-hNGF) monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range, inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo without having a significant adverse effect on the immune system of the patient.SELECTED DRAWING: None【課題】喘息、関節炎及び乾癬を含む種々のNGF関連疾患の治療で抗-NGF抗体を使用する方法の提供。【解決手段】患者の免疫系に対して有意な副作用がなく、ナノモル濃度の範囲の親和性でｈＮＧＦと結合することが可能な抗－ヒトＮＧＦ（抗－ｈＮＧＦ）モノクローナル抗体の有効量をヒト患者へ投与し、インビボでのヒトＴｒｋＡ（ｈＴｒｋＡ）とｈＮＧＦとの結合を阻害することを含んでなる、ヒト患者でのＮＧＦ－関連疾患をコントロールする方法。【選択図】なし
